Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Dec 30
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Experts predict massive growth in health tech

Apr 7
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Virtuous Cycle: Innovation and Investment

Nov 3
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Cambridge-1 and the future of medicine

Oct 7
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Amazon Genomics CLI is Open Source, UK Biobank’s Research Analysis Platform Live

Aug 29
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Why AI is so difficult to apply in finance

Nov 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Four major impacts of artificial intelligence on healthcare

Oct 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Big-name U.S. tech investors are moving in on Europe in increasing numbers

Sep 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Venture capitalists raise more than $100bn to target life sciences

Sep 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Arabesque launches the world’s first AI-powered ESG portfolio manager

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted